News about Global Pharma

YS Biopharma Announces Name Change to LakeShore Biopharma

The name change and trading symbol change will not affect any rights of shareholders or the Company's operations and financial position. The Company's ordinary shares and warrants will continue to be listed on the Nasdaq.

Global Pharma | 24/05/2024 | By Manvi |  529

Biossmann Appoints Pankaj Kedia as Chief AI Officer to Drive Global Expansion and Innovation

Kedia, a renowned technology industry executive and AI thought-leader, joins Biossmann to spearhead its global expansion and drive innovation, positioning the company as a powerhouse in medical solutions.

Global Pharma | 24/05/2024 | By Abha |  999

Indica Labs and Hamamatsu Photonics Receive FDA Clearance for HALO AP Dx Digital Pathology Platform

HALO AP Dx is indicated for the primary diagnosis of surgical pathology slides prepared from formalin-fixed paraffin-embedded (FFPE) tissue scanned by the NanoZoomer® S360MD Slide scanner.

Global Pharma | 24/05/2024 | By Abha |  624

Gland Pharma Reports Remarkable Q4FY24 and FY24 Financial Performance

Gland Pharma Ltd. has announced its financial results for the fourth quarter (Q4FY24) and full year (FY24) ended on Mar 31, 2024.

Global Pharma | 23/05/2024 | By Aishwarya |  944

CAI and Fedegari Group to Deliver Turnkey Sterilization Solutions to Pharma Manufacturers

CAI has inked a strategic partnership with Fedegari Group, a manufacturer and service provider of high-performance sterilization systems.

Global Pharma | 23/05/2024 | By Aishwarya |  371

Strides Announces Best-Ever Financial Results for FY24

Strides Pharma Science Ltd. has published its consolidated financial results for the quarter (Q4FY24) and full year (FY24) ended March 31, 2024.

Global Pharma | 23/05/2024 | By Aishwarya |  1510

LabGenius Raises EUR 35 Million to Develop its ML-Driven Antibody Discovery Platform

LabGenius, a drug discovery company pioneering the use of machine learning for the discovery of novel therapeutic antibodies, has secured EUR 35 million in Series B financing round.

Global Pharma | 23/05/2024 | By Aishwarya |  862

Dragonfly Therapeutics Partners with Merck to Evaluate DF9001

Dragonfly Therapeutics, Inc. has entered into a clinical collaboration with Merck (known as MSD outside the US and Canada), to evaluate DF9001, Dragonfly's EGFR immune engager, in combination with Merck's anti-PD-1 therapy, KEYTRUDA (pembrolizumab), in patients with advanced solid tumors expressing EGFR.

Global Pharma | 22/05/2024 | By Aishwarya |  629

Valneva Names Dr. Hanneke Schuitemaker as Chief Scientific Officer

Valneva has appointed Dr. Hanneke Schuitemaker, PhD as Chief Scientific Officer (CSO) and Executive Committee member, effective June 3, 2024.

Global Pharma | 22/05/2024 | By Aishwarya |  515

PharmaLytica 2024 to Mark a Decade of Excellence and Innovation for Pharma Manufacturing

PharmaLytica Expo has been approaching its milestone 10th edition launch, scheduled from May 30, 2024 to June 1, 2024, at HITEX, Hyderabad a prominent pharmaceutical hub in India.

Global Pharma | 22/05/2024 | By Aishwarya |  973